Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
In the latest session, Cognition Therapeutics Inc (NASDAQ: CGTX) closed at $1.38 down -2.82% from its previous closing price of $1.42. In other words, the price has decreased by -$2.82 from its previous closing price. On the day, 0.65 million shares were traded. CGTX stock price reached its highest trading level at $1.4345 during the session, while it also had its lowest trading level at $1.37.
Ratios:
For a deeper understanding of Cognition Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.44 and its Current Ratio is at 6.44. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In the most recent recommendation for the company, B. Riley Securities on December 19, 2024, Upgraded its rating to Buy and sets its target price to $1.50 from $1 previously.
On November 03, 2021, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $22.Oppenheimer initiated its Outperform rating on November 03, 2021, with a $22 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jan 31 ’25 when Ricciardi Lisa bought 38,851 shares for $0.77 per share. The transaction valued at 30,001 led to the insider holds 38,851 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CGTX now has a Market Capitalization of 121818472 and an Enterprise Value of 82864480.
Stock Price History:
The Beta on a monthly basis for CGTX is 1.26, which has changed by 1.0821114 over the last 52 weeks, in comparison to a change of 0.15507638 over the same period for the S&P500. Over the past 52 weeks, CGTX has reached a high of $3.83, while it has fallen to a 52-week low of $0.22. The 50-Day Moving Average of the stock is -10.67%, while the 200-Day Moving Average is calculated to be 21.92%.
Shares Statistics:
For the past three months, CGTX has traded an average of 1.04M shares per day and 938860 over the past ten days. A total of 88.27M shares are outstanding, with a floating share count of 80.04M. Insiders hold about 9.33% of the company’s shares, while institutions hold 17.59% stake in the company. Shares short for CGTX as of 1767139200 were 5791349 with a Short Ratio of 5.57, compared to 1764288000 on 6396928. Therefore, it implies a Short% of Shares Outstanding of 5791349 and a Short% of Float of 7.0700005.
Earnings Estimates
. The current market rating for Cognition Therapeutics Inc (CGTX) reflects the collective analysis of 4.0 analysts closely monitoring its performance.The consensus estimate for the next quarter is -$0.06, with high estimates of -$0.05 and low estimates of -$0.07.
Analysts are recommending an EPS of between -$0.34 and -$0.51 for the fiscal current year, implying an average EPS of -$0.39. EPS for the following year is -$0.34, with 4.0 analysts recommending between -$0.21 and -$0.46.
